Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

1.89
Delayed Data
As of 2:00pm ET
 -0.0299 / -1.56%
Today’s Change
1.81
Today|||52-Week Range
3.40
-8.69%
Year-to-Date
3 Beaten-Down Biotech Stocks You Can Buy Right Now
Jan 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.92
Today’s open1.93
Day’s range1.87 - 1.95
Volume1,115,042
Average volume (3 months)1,542,711
Market cap$305.6M
Dividend yield--
Data as of 2:00pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.14

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...+0.07+0.66%
ADAPAdaptimmune Therapeu...-0.05-1.20%
AGENAgenus Inc+0.01+0.26%
BOLDAudentes Therapeutic...-0.04-0.24%
Data as of 2:14pm ET, 01/24/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs